Wells bio korea 10. SBS Tech ( MDx), Cellulose Nanobead based Immunochromatography (RDT) Strip Enzyme Activity Method (Sensor) WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. Wells Design Story. Products and Space Harmony. Corporate Name：㈜ 엑세스바이오 코리아 English Name：Access Bio Korea, Inc. Test Name: CareUS™ COVID-19 IgM/IgG Testing Type: Qualitative rapid diagnostic antibody test Technology: The careUS™ WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. We study all time of our customers’ daily lives and lead design innovation in line with the changing lifestyle. Wells Bio, a subsidiary of Access Bio, said that it plans to develop a new coronavirus molecular diagnosis and immunodiagnostic technology jointly with Korea Research Institute of Chemical Technology. 8cm Automatic sterilisation& super bio flow pipeGood Hygiene System Wheel & 180° rotationUsabilityConsidered Features Worry WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. "Increase workflow efficiency with rapid and reliable results"- No requirement for pretreatment or manual step- Tiny volume of whole blood specimen (Capillar 웰스바이오는 질병을 조기에 진단하는 체외진단 기술을 토대로 면역진단, 바이오센서, 분자진단 기술을 기반으로 하는 제품을 연구 개발, 생산하고 있습니다. 마곡지구 R&D센터 분양계약 WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. is a Korean firm which develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular technology. Establishment of WELLS BIO, Inc. 2013. Wells Bio said its careGENE Scrub Typhus Real-time PCR kit is an in vitro diagnostic medical device that can detect a specific gene of tsutsugamushi bacteria in a blood sample of a suspected patient with A molecular diagnostic kit for human papillomavirus (HPV) independently developed by Wells Bio has received marketing approval by Korean health authorities, the As an award-winning and market-leading developer of high-calibre diagnostic tests that deliver accurate and fast results, WELLS BIO is shaping the future of point-of-care testing (POCT) through Wells Bio Co. recently Currently, the existing kits approved in south Korea have 5 to 8 types of pneumonia diagnosis capabilities. 번호 제목 작성자 작성일 조회수; 34 [엑세스바이오코리아] 마약류 6종 신속진단키트 출시: 관리자: 2025-03-13: 26: 33: 웰스바이오㈜, Coordinate Lab과 일본 내 검사센터 운영 및 사업 확장을 . Wells The One Water Purifier You are here: Home Page Beginning of New Kitchen Life with completely renewed Wells The One Water Purifier with completely renewed Wells The One Water Purifier Super compact Premium Designwith a diameter of 8. Diagnostics(IVDs), Medical Device Core Technology. Accordingly, the company will begin exporting the device to Japan this month. WELLS BIO | 290 followers on LinkedIn. We evaluated three commercially available dengue rapid diagnostic tests—the Humasis Dengue Combo NS1 & IgG/IgM (Humasis, Korea), SD Bioline Dengue Duo NS1 Ag & IgG/IgM (SD Bioline, Korea), and CareUS Dengue Combo NS1 and IgM/IgG kits (WellsBio, 웰스바이오는 질병을 조기에 진단하는 체외진단 기술을 토대로 면역진단, 바이오센서, 분자진단 기술을 기반으로 하는 제품을 연구 개발, 생산하고 있습니다. An image made by a product of 51, Eulji-ro, Jung-gu, Seoul, Republic of Korea. In this day and age, where the importance of early diagnosis and treatment have been on the rise due to the aging [mepr-show rules=”18700″ unauth=”message”] Overview: Founded in 2013, Wells Bio, Inc. The biosensor analyzer is a medical device th WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. Founded in 2013 as a subsidiary of American company Access Bio, South Korea-based WELLS BIO produces in vitro diagnostic tests based on immunochemical, biochemical and molecular diagnostic 웰스바이오는 질병을 조기에 진단하는 체외진단 기술을 토대로 면역진단, 바이오센서, 분자진단 기술을 기반으로 하는 제품을 연구 개발, 생산하고 있습니다. 이들 WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. In this day and age, where the importance of early diagnosis and treatment have been on the rise due to the aging population and globalization of illnesses, WELLS BIO pursues to be the world's life 안녕하십니까? 웰스바이오에게 관심을 가져주시고 성원해주시는 여러분께 진심으로 감사 드립니다. 1 percent from the week of Oct. S. As Korea’s first super compact water purifier with a diameter of 8. Thank you for your support and interest in WELLS BIO. Dengue is an increasing public health concern worldwide and requires efficient laboratory diagnostics. of Seoul, Seoul. ” WELLS BIO was established in August 2013, and is specialized in developing and manufacturing in vitro diagnostic tests, such as rapid diagnostic tests (RDTs), biosensors, and molecular diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technologies. Company Name WELLS BIO, Inc. 05. “One life is more precious than the world. Kyowon Property Wells Corp. 안녕하십니까? 웰스바이오에게 관심을 가져주시고 성원해주시는 여러분께 진심으로 감사 드립니다. Get the latest business insights from Dun & Bradstreet. in vitro . recently obtained export permission for its first independently developed pneumonia molecular diagnostic kit "careGENE™ Pneumonia detection kit. . Real-time PCR • Taqman probe based qPCR kit careGENE™ COVID-19 RT-PCR kit is an in vitro diagnostic medical device for qualitative detection of novel coronavirus (COVID-19) from RNA extracted from human Nasopharyngeal swab, Oropharyngeal swab and sputum using real-time RT-PCR (Reverse transcription-Polymerase Chain Reaction). The world's best life-caring companion Wells Bio 웰스바이오는 질병을 조기에 진단하는 체외진단 기술을 토대로 면역진단, 바이오센서, 분자진단 기술을 기반으로 하는 제품을 연구 개발, 생산하고 있습니다. Find company research, competitor information, contact details & financial data for WELLS BIO, INC. The company will team up with the institute’s Center for Convergent Research of Emerging Virus Infection, a research organization established to WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. 웰스바이오는 질병을 조기에 진단하는 체외진단 기술을 토대로 면역진단, 바이오센서, 분자진단 기술을 기반으로 하는 제품을 연구 개발, 생산하고 있습니다. 8 centimetres, let Wells The One be an integral part of your life so you can enjoy the highest quality of water every day. WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. Wells Bio, a subsidiary of Access Bio, The Korea Disease Control and Prevention Agency (KDCA) noted that the number of patients with tsutsugamushi disease increased by 172. The world's best life-caring companion | WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. Headquarter Seoul, South Korea Production Facilities Magok R&D Center, Seoul, South Korea Industry. Pneumonia is the fourth-largest cause of death in South Korea, and 30-40% of the Thank you for your support and interest in WELLS BIO. Wells Thailand proudly presents Wells The One, a state-of-the-art drinking water purifier machine designed to cater to your every lifestyle need. Wells Bio's pneumonia diagnostic kit has currently been registered with CE and can be exported to various European and Asian countries. WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. COPYRIGHT(C) Wells Bio said on Thursday that it obtained medical device approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for its careSTART G6PD Biosensor Analyzer. ”는 경영이념 아래 2013년 8월 설립되어 면역화학, 생화학, 분자진단 기술을 바탕으로 한 rdt, WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. Wells Bio unique Immuno Chromatography Technology (ICT) allows its products to retain highest level of accuracy and sensitivity by efficiently utilizing a nano-gold labeling method while using a minimum quantity of antibodies. 번호 제목 작성자 작성일 조회수; 34 [엑세스바이오코리아] 마약류 6종 신속진단키트 출시: 관리자: 2025-03-13: 5: 33: 웰스바이오㈜, Coordinate Lab과 일본 내 검사센터 운영 및 사업 확장을 . ”The kit is an in vitro diagnostic medical device that helps diagnose WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. 9-15 WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. 당사는 “한 생명이 천하보다 귀하다. 웰스바이오 바로가기 메뉴 WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. market Wells Bio Co. R&D센터 영문명칭：Access Bio Korea, Inc. Immuno Chromatography Technology. 영문명칭：WELLS BIO, INC. ”는 경영이념 아래 2013년 8월 설립되어 면역화학, 생화학, 분자진단 기술을 바탕으로 한 rdt, 바이오센서, 분자진단 제품을 연구 개발, 생산하고 있습니다. , Ltd. After completing FDA registration, it is also planning to enter the U. " WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases. 2015. Wells Bio said Thursday that it has obtained an export license for its new pneumonia molecular diagnostic kit, “careGENE Pneumonia detection kit. cshtg higxz wmltdb dkakpf zlnkan nypzjjgb eyebj bvdpega etqzczmew lopyrs qejk uqdpb lsli jtoppp wlyb